Sjögren's Syndrome as an Immune-related Adverse Event of Nivolumab Treatment for Gastric Cancer

Immune checkpoint inhibitors can affect any organ, including the salivary glands. A case of Sjögren's syndrome (SjS) induced by nivolumab for the treatment of gastric cancer is herein presented. Nivolumab treatment caused marked tumor shrinkage, but xerostomia developed after two cycles. It too...

Descripción completa

Detalles Bibliográficos
Autores principales: Higashi, Tetsuo, Miyamoto, Hideaki, Yoshida, Ryoji, Furuta, Yoki, Nagaoka, Katsuya, Naoe, Hideaki, Naito, Hisaki, Nakayama, Hideki, Tanaka, Motohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662059/
https://www.ncbi.nlm.nih.gov/pubmed/32581160
http://dx.doi.org/10.2169/internalmedicine.4701-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662059/
https://www.ncbi.nlm.nih.gov/pubmed/32581160
http://dx.doi.org/10.2169/internalmedicine.4701-20

Ejemplares similares